110 related articles for article (PubMed ID: 15172047)
21. Abatacept.
Moreland L; Bate G; Kirkpatrick P
Nat Rev Drug Discov; 2006 Mar; 5(3):185-6. PubMed ID: 16557658
[No Abstract] [Full Text] [Related]
22. Abatacept therapy for rheumatoid arthritis in the setting of hepatitis C infection.
Mahajan TD; Hooker R; Maher L; Brown G; Reimold A
J Clin Rheumatol; 2010 Oct; 16(7):332-4. PubMed ID: 20859223
[TBL] [Abstract][Full Text] [Related]
23. Immunization of patients with rheumatoid arthritis with antitumor necrosis factor alpha therapy and methotrexate.
Brezinschek HP; Hofstaetter T; Leeb BF; Haindl P; Graninger WB
Curr Opin Rheumatol; 2008 May; 20(3):295-9. PubMed ID: 18388521
[TBL] [Abstract][Full Text] [Related]
24. Abatacept in biologic-naïve patients and TNF inadequate responders: clinical data in focus.
Sherrer Y
Curr Med Res Opin; 2008 Aug; 24(8):2283-94. PubMed ID: 18590608
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic efficacy of experimental rheumatoid arthritis with low-dose methotrexate by increasing partially CD4+CD25+ Treg cells and inducing Th1 to Th2 shift in both cells and cytokines.
Xinqiang S; Fei L; Nan L; Yuan L; Fang Y; Hong X; Lixin T; Juan L; Xiao Z; Yuying S; Yongzhi X
Biomed Pharmacother; 2010 Sep; 64(7):463-71. PubMed ID: 20359858
[TBL] [Abstract][Full Text] [Related]
26. Combination sulfasalazine and methotrexate in the management of rheumatoid arthritis.
Shiroky JB
J Rheumatol Suppl; 1996 Mar; 44():69-71. PubMed ID: 8833057
[TBL] [Abstract][Full Text] [Related]
27. Indirect treatment comparison of abatacept with methotrexate versus other biologic agents for active rheumatoid arthritis despite methotrexate therapy in the United kingdom.
Guyot P; Taylor PC; Christensen R; Pericleous L; Drost P; Eijgelshoven I; Bergman G; Lebmeier M
J Rheumatol; 2012 Jun; 39(6):1198-206. PubMed ID: 22505698
[TBL] [Abstract][Full Text] [Related]
28. TNF-alpha antagonists and other recombinant proteins for the treatment of rheumatoid arthritis.
Brasington R
J Hand Surg Am; 2009 Feb; 34(2):349-50. PubMed ID: 19135810
[No Abstract] [Full Text] [Related]
29. The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis.
Cohen SB
Rheum Dis Clin North Am; 2004 May; 30(2):365-80, vii. PubMed ID: 15172046
[TBL] [Abstract][Full Text] [Related]
30. T cell lessons from the rheumatoid arthritis synovium SCID mouse model: CD3-rich synovium lacks response to CTLA-4Ig but is successfully treated by interleukin-17 neutralization.
Koenders MI; Marijnissen RJ; Joosten LA; Abdollahi-Roodsaz S; Di Padova FE; van de Loo FA; Dulos J; van den Berg WB; Boots AM
Arthritis Rheum; 2012 Jun; 64(6):1762-70. PubMed ID: 22213107
[TBL] [Abstract][Full Text] [Related]
31. Safety profile of abatacept in rheumatoid arthritis: a review.
Khraishi M; Russell A; Olszynski WP
Clin Ther; 2010 Oct; 32(11):1855-70. PubMed ID: 21095481
[TBL] [Abstract][Full Text] [Related]
32. Putting new disease-modifying antirheumatic drugs into perspective.
Saseen JJ
Pharmacotherapy; 2007 Dec; 27(12):1609-10. PubMed ID: 18041880
[No Abstract] [Full Text] [Related]
33. Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF alpha and IL18 but not CXCL12.
van Oosterhout M; Levarht EW; Sont JK; Huizinga TW; Toes RE; van Laar JM
Ann Rheum Dis; 2005 Apr; 64(4):537-43. PubMed ID: 15769913
[TBL] [Abstract][Full Text] [Related]
34. Do gold shots really work for rheumatoid arthritis?
Meenan RF
Bull Rheum Dis; 1991; 40(5):6-7. PubMed ID: 1686734
[No Abstract] [Full Text] [Related]
35. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.
Edwards JC; Szczepanski L; Szechinski J; Filipowicz-Sosnowska A; Emery P; Close DR; Stevens RM; Shaw T
N Engl J Med; 2004 Jun; 350(25):2572-81. PubMed ID: 15201414
[TBL] [Abstract][Full Text] [Related]
36. Update 2011: leflunomide in rheumatoid arthritis - strengths and weaknesses.
Behrens F; Koehm M; Burkhardt H
Curr Opin Rheumatol; 2011 May; 23(3):282-7. PubMed ID: 21427581
[TBL] [Abstract][Full Text] [Related]
37. Abatacept as add-on therapy for rheumatoid arthritis.
Allison C
Issues Emerg Health Technol; 2005 Sep; (73):1-4. PubMed ID: 16317826
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritis.
Gerards AH; de Lathouder S; de Groot ER; Dijkmans BA; Aarden LA
Rheumatology (Oxford); 2003 Oct; 42(10):1189-96. PubMed ID: 12777636
[TBL] [Abstract][Full Text] [Related]
39. Rheumatoid arthritis: choice of antirheumatic treatment. Methotrexate first.
Prescrire Int; 2010 Feb; 19(105):30-4. PubMed ID: 20455343
[TBL] [Abstract][Full Text] [Related]
40. [CTLA4-Ig].
Miyasaka N
Nihon Rinsho; 2005 May; 63 Suppl 5():751-5. PubMed ID: 15954440
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
